Develops MRI-guided ultrasound systems for prostate cancer and uterine fibroids.
Jun 2026Revenue $19.1M/yrExpenses $54.5M/yr
No trendCash runway ≈ 1.1 years from Jun 2026
Figures by year
When will Profound Medical be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $19.1M and expenses $54.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $16.1M | $57.4M | −$41.3M |
| Dec 2024 | $10.7M | $43.7M | −$33.1M |
| Dec 2023 | $7.20M | $35.9M | −$28.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.